Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Texas

Phase 2 colorectal cancer trials in Texas

29 Phase 2 colorectal cancer studies are recruiting participants at sites in 13 cities across Texas as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Texas by city

Cities with the most studies recruiting right now.

Every Texas city with a recruiting study

Houston (20), Austin (4), Dallas (3), Fort Worth (2), Kingwood (2), Laredo (2), San Antonio (2), Tyler (2), Beaumont (1), Grapevine (1), Temple (1), Texas City (1), Webster (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Texas

Basic details from each study's public record (the 12 most recently updated of 29). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Fort Worth · Houston
    Registry record
    NCT07659795 · updated
  2. Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT06959550 · updated
  3. Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Houston
    Registry record
    NCT04557449 · updated
  4. A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT05411718 · updated
  5. Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Riboscience, LLC.
    Recruiting in
    Kingwood
    Registry record
    NCT06824064 · updated
  6. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Recruiting in
    Houston
    Registry record
    NCT07446322 · updated
  7. A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Jazz Pharmaceuticals
    Recruiting in
    Dallas · Houston
    Registry record
    NCT06695845 · updated
  8. A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Bayer
    Recruiting in
    Houston
    Registry record
    NCT06760819 · updated
  9. A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Austin · Webster
    Registry record
    NCT06820463 · updated
  10. A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Criterium, Inc.
    Recruiting in
    San Antonio
    Registry record
    NCT06992258 · updated
  11. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Austin · Fort Worth · Grapevine · and 1 more U.S. location
    Registry record
    NCT07023289 · updated
  12. 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    The Methodist Hospital Research Institute
    Recruiting in
    Houston
    Registry record
    NCT06887218 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Texas on ClinicalTrials.gov.

Ask about studies in Texas

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call